Current and historical daily PE Ratio for Pharmaron Beijing Co Ltd (
) from 2019 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pharmaron Beijing stock (SZSE:300759) PE ratio as of Jun 09 2024 is 23.39.
More Details
Pharmaron Beijing Co Ltd (SZSE:300759) PE Ratio (TTM) Chart
Pharmaron Beijing Co Ltd (SZSE:300759) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Pharmaron Beijing PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 23.4 | 2024-04-01 | 25.1 |
| 2024-06-07 | 23.4 | 2024-03-29 | 24.4 |
| 2024-06-06 | 23.6 | 2024-03-28 | 24.4 |
| 2024-06-05 | 23.7 | 2024-03-27 | 22.4 |
| 2024-06-04 | 23.4 | 2024-03-26 | 23.1 |
| 2024-06-03 | 23.0 | 2024-03-25 | 23.4 |
| 2024-05-31 | 24.7 | 2024-03-22 | 23.6 |
| 2024-05-30 | 25.0 | 2024-03-21 | 24.8 |
| 2024-05-29 | 25.0 | 2024-03-20 | 25.3 |
| 2024-05-28 | 24.8 | 2024-03-19 | 25.3 |
| 2024-05-27 | 25.1 | 2024-03-18 | 26.1 |
| 2024-05-24 | 25.2 | 2024-03-15 | 25.3 |
| 2024-05-23 | 25.6 | 2024-03-14 | 25.7 |
| 2024-05-22 | 26.4 | 2024-03-13 | 25.7 |
| 2024-05-21 | 26.1 | 2024-03-12 | 25.9 |
| 2024-05-20 | 26.5 | 2024-03-11 | 25.4 |
| 2024-05-17 | 26.6 | 2024-03-08 | 24.3 |
| 2024-05-16 | 26.6 | 2024-03-07 | 24.1 |
| 2024-05-15 | 26.6 | 2024-03-06 | 26.9 |
| 2024-05-14 | 26.9 | 2024-03-05 | 26.8 |
| 2024-05-13 | 26.6 | 2024-03-04 | 27.5 |
| 2024-05-10 | 26.0 | 2024-03-01 | 25.7 |
| 2024-05-09 | 25.0 | 2024-02-29 | 25.9 |
| 2024-05-08 | 23.9 | 2024-02-28 | 24.9 |
| 2024-05-07 | 24.3 | 2024-02-27 | 25.1 |
| 2024-05-06 | 24.4 | 2024-02-26 | 24.8 |
| 2024-04-30 | 23.6 | 2024-02-23 | 24.5 |
| 2024-04-29 | 23.9 | 2024-02-22 | 24.5 |
| 2024-04-26 | 22.9 | 2024-02-21 | 24.3 |
| 2024-04-25 | 21.8 | 2024-02-20 | 24.1 |
| 2024-04-24 | 21.7 | 2024-02-19 | 23.6 |
| 2024-04-23 | 22.1 | 2024-02-08 | 23.3 |
| 2024-04-22 | 21.7 | 2024-02-07 | 22.9 |
| 2024-04-19 | 21.8 | 2024-02-06 | 22.9 |
| 2024-04-18 | 22.6 | 2024-02-05 | 21.2 |
| 2024-04-17 | 22.7 | 2024-02-02 | 21.7 |
| 2024-04-16 | 21.8 | 2024-02-01 | 23.6 |
| 2024-04-15 | 22.8 | 2024-01-31 | 23.4 |
| 2024-04-12 | 22.9 | 2024-01-30 | 24.9 |
| 2024-04-11 | 23.2 | 2024-01-29 | 24.5 |
| 2024-04-10 | 23.7 | 2024-01-26 | 24.4 |
| 2024-04-09 | 24.4 | 2024-01-25 | 28.0 |
| 2024-04-08 | 23.5 | 2024-01-24 | 27.4 |
| 2024-04-03 | 24.4 | 2024-01-23 | 27.5 |
| 2024-04-02 | 24.6 | 2024-01-22 | 27.3 |
Pharmaron Beijing Co Ltd (SZSE:300759) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Pharmaron Beijing Co Ltd
ISIN : CNE100003JW4
Share Class Description:
SZSE:300759: Class ACompare
Compare
Traded in other countries / regions
300759.China03759.Hong KongPHBBF.USA17Q1.Germany IPO Date
2019-01-28Description
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers